Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2008-8-12
pubmed:abstractText
New topical treatments in scalp psoriasis are needed because many current topical treatments are disliked by patients and associated with poor compliance.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1097-6787
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
59
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
455-63
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:18694678-Administration, Cutaneous, pubmed-meshheading:18694678-Adolescent, pubmed-meshheading:18694678-Adult, pubmed-meshheading:18694678-Aged, pubmed-meshheading:18694678-Aged, 80 and over, pubmed-meshheading:18694678-Anti-Inflammatory Agents, pubmed-meshheading:18694678-Betamethasone, pubmed-meshheading:18694678-Calcitriol, pubmed-meshheading:18694678-Dermatologic Agents, pubmed-meshheading:18694678-Double-Blind Method, pubmed-meshheading:18694678-Drug Combinations, pubmed-meshheading:18694678-Female, pubmed-meshheading:18694678-Humans, pubmed-meshheading:18694678-Male, pubmed-meshheading:18694678-Middle Aged, pubmed-meshheading:18694678-Pharmaceutical Vehicles, pubmed-meshheading:18694678-Psoriasis, pubmed-meshheading:18694678-Scalp Dermatoses, pubmed-meshheading:18694678-Severity of Illness Index, pubmed-meshheading:18694678-Skin, pubmed-meshheading:18694678-Treatment Outcome
pubmed:year
2008
pubmed:articleTitle
A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
pubmed:affiliation
Department of Dermatology, Health Sciences Faculty University of Copenhagen, Roskilde Hospital, Roskilde, Denmark. gbj@regionsjaelland.dk
pubmed:publicationType
Journal Article, Comparative Study, Randomized Controlled Trial, Multicenter Study